Jörge E. Cortes
Jörge E. Cortes publishes mostly in Hematology, Genetics and Public Health, Environmental and Occupational Health, on topics such as Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Acute Myeloid Leukemia Research.
- World rank
- #146,620 of 7,710,434 ranked researchers
- Rank in United States
- #55,376 of 1,627,098
- Works
- 3,564
- Citations
- 146k
- Citations per work
- 41.1
What does Jörge E. Cortes research?
Jörge E. Cortes's work is mostly in Medicine (77%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2,75577.3%
- Medicine2,75577.3%
- Everything else56015.7%
- Life Sciences2497.0%
- 1Hematology38% of their works
- 2Genetics20% of their works
- 3Public Health, Environmental and Occupational Health7% of their works
- 4Molecular Biology7% of their works
- 5Rheumatology7% of their works
- 6Oncology6% of their works
Research topics
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Eosinophilic Disorders and Syndromes
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Lymphoma Diagnosis and Treatment
Which keywords describe Jörge E. Cortes's research?
The keywords of their largest research topics: Prognostic Factors, BCR-ABL, Imatinib, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Acute Myeloid Leukemia and AML.
- Molecular Profiling
- International Myeloma Working Group
- Myelofibrosis
- Hypereosinophilic Syndrome
- Childhood Cancer
- Classification
- Acute Myeloid Leukemia
- Genomic Aberrations
- Rituximab
- BCR-ABL
- Prognostic Factors
- Imatinib
- Chronic Lymphocytic Leukemia
- AML
- Minimal Residual Disease
- Acute Lymphoblastic Leukemia
- Fusion Genes
- JAK2 Mutation
- Diagnosis Criteria
- Lymphoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Prognostic Factors3,5543 topics
- BCR-ABL2,0481 topic
- Imatinib2,0481 topic
- Rituximab1,6222 topics
- Chronic Lymphocytic Leukemia1,4311 topic
- Genomic Aberrations1,4311 topic
- AML1,4181 topic
- Acute Myeloid Leukemia1,4181 topic
- Minimal Residual Disease9042 topics
- Classification8452 topics
- Acute Lymphoblastic Leukemia7051 topic
- Childhood Cancer7051 topic
- Fusion Genes6541 topic
- Hypereosinophilic Syndrome6541 topic
- JAK2 Mutation5041 topic
- Myelofibrosis5041 topic
- Diagnosis Criteria1991 topic
- International Myeloma Working Group1991 topic
- Lymphoma1911 topic
- Molecular Profiling1911 topic
Where does Jörge E. Cortes work?
Jörge E. Cortes's main affiliation in the publication record is The University of Texas MD Anderson Cancer Center, United States.
How many publications and citations does Jörge E. Cortes have?
OpenAlex counts 3,564 works and 146,413 citations for Jörge E. Cortes, an h-index of 182, ranking #146,620 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Jörge E. Cortes
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jörge E. Cortes. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.